170 related articles for article (PubMed ID: 25209384)
1. Prognostic factors and survival rates for parotid duct carcinoma patients.
Shi S; Fang Q; Liu F; Zhong M; Sun C
J Craniomaxillofac Surg; 2014 Dec; 42(8):1929-31. PubMed ID: 25209384
[TBL] [Abstract][Full Text] [Related]
2. Clinical prognostic factors in malignant parotid gland tumors.
Lima RA; Tavares MR; Dias FL; Kligerman J; Nascimento MF; Barbosa MM; Cernea CR; Soares JR; Santos IC; Salviano S
Otolaryngol Head Neck Surg; 2005 Nov; 133(5):702-8. PubMed ID: 16274796
[TBL] [Abstract][Full Text] [Related]
3. Carcinoma of the parotid gland: developing prognostic indices.
Lequerica-Fernández P; Peña I; Villalaín L; Rosado P; de Vicente JC
Int J Oral Maxillofac Surg; 2011 Aug; 40(8):821-8. PubMed ID: 21612890
[TBL] [Abstract][Full Text] [Related]
4. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
[TBL] [Abstract][Full Text] [Related]
5. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
6. Oncological outcome and prognostic factors in malignant parotid tumours.
Mercante G; Marchese C; Giannarelli D; Pellini R; Cristalli G; Manciocco V; Ruscito P; Pichi B; Marchesi P; Spriano G
J Craniomaxillofac Surg; 2014 Jan; 42(1):59-65. PubMed ID: 23541937
[TBL] [Abstract][Full Text] [Related]
7. Treatment of carcinoma of the parotid gland: the results of a multicenter study.
Tullio A; Marchetti C; Sesenna E; Brusati R; Cocchi R; Eusebi V
J Oral Maxillofac Surg; 2001 Mar; 59(3):263-70. PubMed ID: 11243607
[TBL] [Abstract][Full Text] [Related]
8. Cancer of the parotid gland; long-term follow-up. A single centre experience on recurrence and survival.
Cederblad L; Johansson S; Enblad G; Engström M; Blomquist E
Acta Oncol; 2009; 48(4):549-55. PubMed ID: 19140053
[TBL] [Abstract][Full Text] [Related]
9. A 20-Year Review of 75 Cases of Salivary Duct Carcinoma.
Gilbert MR; Sharma A; Schmitt NC; Johnson JT; Ferris RL; Duvvuri U; Kim S
JAMA Otolaryngol Head Neck Surg; 2016 May; 142(5):489-95. PubMed ID: 26939990
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma. A significant factor in local control and distant metastasis.
Chua DT; Sham JS; Kwong DL; Choy DT; Au GK; Wu PM
Cancer; 1996 Jul; 78(2):202-10. PubMed ID: 8673993
[TBL] [Abstract][Full Text] [Related]
11. Survival in patients with parotid gland carcinoma - Results of a multi-center study.
Honda K; Tanaka S; Shinohara S; Asato R; Tamaki H; Maetani T; Tateya I; Kitamura M; Takebayashi S; Ichimaru K; Kitani Y; Kumabe Y; Kojima T; Ushiro K; Mizuta M; Yamada K; Omori K
Am J Otolaryngol; 2018; 39(1):65-70. PubMed ID: 29089142
[TBL] [Abstract][Full Text] [Related]
12. Salivary duct carcinoma: what is already known, and can we improve survival?
Wee DT; Thomas AA; Bradley PJ
J Laryngol Otol; 2012 Jul; 126 Suppl 2():S2-7. PubMed ID: 22495125
[TBL] [Abstract][Full Text] [Related]
13. Mucoepidermoid carcinoma of the parotid gland treated by surgery and postoperative radiation therapy: clinicopathologic correlates of outcome.
Chen AM; Lau VH; Farwell DG; Luu Q; Donald PJ
Laryngoscope; 2013 Dec; 123(12):3049-55. PubMed ID: 23754320
[TBL] [Abstract][Full Text] [Related]
14. Parotid salivary duct carcinoma: a single institution's 20-year experience.
Stodulski D; Mikaszewski B; Majewska H; Kuczkowski J
Eur Arch Otorhinolaryngol; 2019 Jul; 276(7):2031-2038. PubMed ID: 31062093
[TBL] [Abstract][Full Text] [Related]
15. Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases.
Jaehne M; Roeser K; Jaekel T; Schepers JD; Albert N; Löning T
Cancer; 2005 Jun; 103(12):2526-33. PubMed ID: 15900577
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of MUC-1 has close relation with patient survivor in high-grade salivary gland mucoepidermoid carcinoma.
Siyi L; Shengwen L; Min R; Wenjun Y; Lizheng W; Chenping Z
J Oral Pathol Med; 2014 Sep; 43(8):579-84. PubMed ID: 24725122
[TBL] [Abstract][Full Text] [Related]
17. Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: a multi-institution study.
Elshaikh MA; Al-Wahab Z; Mahdi H; Albuquerque K; Mahan M; Kehoe SM; Ali-Fehmi R; Rose PG; Munkarah AR
Gynecol Oncol; 2015 Feb; 136(2):235-9. PubMed ID: 25511158
[TBL] [Abstract][Full Text] [Related]
18. Survival rates and prognostic factors for infiltrating salivary duct carcinoma: Analysis of 228 cases from the Surveillance, Epidemiology, and End Results database.
Jayaprakash V; Merzianu M; Warren GW; Arshad H; Hicks WL; Rigual NR; Sullivan MA; Seshadri M; Marshall JR; Cohan DM; Zhao Y; Singh AK
Head Neck; 2014 May; 36(5):694-701. PubMed ID: 23606370
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic analysis of adenoid cystic carcinoma of major salivary glands of 64 cases].
Qing J; Zhang Q; Wei MW; Guo ZM
Ai Zheng; 2006 Sep; 25(9):1138-43. PubMed ID: 16965658
[TBL] [Abstract][Full Text] [Related]
20. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.
Moore BA; Weber RS; Prieto V; El-Naggar A; Holsinger FC; Zhou X; Lee JJ; Lippman S; Clayman GL
Laryngoscope; 2005 Sep; 115(9):1561-7. PubMed ID: 16148695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
